Stock Market & Financial Investment News

News Breaks January 16, 2013 08:13 EDT CELG Celgene price target raised to $107 from $92 at RW Baird Baird raised its price target on Celgene following its long term guidance update. The firm cited its recently announced psoriasis Phase lll success, a heightened focus on returning capital to shareholders, and a rapidly diversifying product portfolio. Shares are Outperform rated. News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 05:51 EDT CELG Stocks with implied volatility movement; CBST CELG Subscribe for More Information May 16, 2013 15:11 EDT CELG Celgene management to meet with JPMorgan Subscribe for More Information 11:50 EDT CELG Celgene, Gilead lower after new data published at ASCO Subscribe for More Information May 7, 2013 07:18 EDT CELG Barclays has increased confidence in Celgene's re-filing of Revlimid Subscribe for More Information May 6, 2013 14:33 EDT CELG Celgene's apremilast had statistical significance for primary endpoint Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.